Inflammatory Markers are Quickly Improved by Tocilizumab in Early Polymyalgia Rheumatica and Might Predict Early Response to Interleukin-6 Blockade
Crossref DOI link: https://doi.org/10.1007/s40744-021-00299-8
Published Online: 2021-03-21
Published Print: 2021-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Carvajal Alegria, Guillermo
Cornec, Divi Y. K.
Renaudineau, Yves
Saraux, Alain
Devauchelle-Pensec, Valérie
Text and Data Mining valid from 2021-03-21
Version of Record valid from 2021-03-21
Article History
Received: 10 November 2020
Accepted: 6 March 2021
First Online: 21 March 2021